Literature DB >> 20425579

Ezetimibe/simvastatin or atorvastatin for the treatment of hypercholesterolemia in patients with the metabolic syndrome: the VYMET study.

Jennifer Villa1, Richard E Pratley.   

Abstract

Entities:  

Year:  2010        PMID： 20425579     DOI： 10.1007/s11892-010-0107-5

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


× No keyword cloud information.
  6 in total

1.  Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease.

Authors:  Scott E Conard; Harold E Bays; Lawrence A Leiter; Steven R Bird; Joseph Rubino; Robert S Lowe; Joanne E Tomassini; Andrew M Tershakovec
Journal:  Am J Cardiol       Date:  2008-10-23       Impact factor: 2.778

2.  Efficacy and safety of ezetimibe added on to atorvastatin (40 mg) compared with uptitration of atorvastatin (to 80 mg) in hypercholesterolemic patients at high risk of coronary heart disease.

Authors:  Lawrence A Leiter; Harold Bays; Scott Conard; Steven Bird; Joseph Rubino; Mary E Hanson; Joanne E Tomassini; Andrew M Tershakovec
Journal:  Am J Cardiol       Date:  2008-10-23       Impact factor: 2.778

3.  Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

Authors: 
Journal:  N Engl J Med       Date:  1998-11-05       Impact factor: 91.245

4.  Intensive versus moderate lipid lowering with statins after acute coronary syndromes.

Authors:  Christopher P Cannon; Eugene Braunwald; Carolyn H McCabe; Daniel J Rader; Jean L Rouleau; Rene Belder; Steven V Joyal; Karen A Hill; Marc A Pfeffer; Allan M Skene
Journal:  N Engl J Med       Date:  2004-03-08       Impact factor: 91.245

5.  Simvastatin with or without ezetimibe in familial hypercholesterolemia.

Authors:  John J P Kastelein; Fatima Akdim; Erik S G Stroes; Aeilko H Zwinderman; Michiel L Bots; Anton F H Stalenhoef; Frank L J Visseren; Eric J G Sijbrands; Mieke D Trip; Evan A Stein; Daniel Gaudet; Raphael Duivenvoorden; Enrico P Veltri; A David Marais; Eric de Groot
Journal:  N Engl J Med       Date:  2008-03-30       Impact factor: 91.245

6.  Extended-release niacin or ezetimibe and carotid intima-media thickness.

Authors:  Allen J Taylor; Todd C Villines; Eric J Stanek; Patrick J Devine; Len Griffen; Michael Miller; Neil J Weissman; Mark Turco
Journal:  N Engl J Med       Date:  2009-11-15       Impact factor: 91.245
  6 in total
  2 in total

1.  A retrospective study on the efficacy of a ten-milligram dosage of atorvastatin for treatment of hypercholesterolemia in type 2 diabetes mellitus patients.

Authors:  Dong Kyun Kim; Sa Rah Lee; Min Sik Kim; Suk Hyang Bae; Jin Yeon Hwang; Jung-Min Kim; Sung Hwan Suh; Hye-Jeong Lee; Mi Kyoung Park; Duk Kyu Kim
Journal:  Korean Diabetes J       Date:  2010-12-31

2.  Response: a retrospective study on the efficacy of a ten-milligram dosage of atorvastatin for treatment of hypercholesterolemia in type 2 diabetes mellitus patients (korean diabetes j 2010;34:359-67).

Authors:  Dong Kyun Kim; Sa Rah Lee; Min Sik Kim; Suk Hyang Bae; Jin Yeon Hwang; Jung-Min Kim; Sung Hwan Suh; Hye-Jeong Lee; Mi Kyoung Park; Duk Kyu Kim
Journal:  Diabetes Metab J       Date:  2011-02-28       Impact factor: 5.376
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.